• 17
  • Comment
  • Favorite

Walgreens Boots Non-GAAP EPS of $0.80 Beats By $0.03, Revenue of $32.45B Beats By $280M

Seeking Alpha2022-10-13

  • Walgreens Boots(NASDAQ: WBA): FQ4 Non-GAAP EPS of $0.80 beats by $0.03.
  • Revenue of $32.45B (-5.3% Y/Y)beats by $280M.
  • FY2023 Outlook: Adjusted EPS of $4.45 to $4.65 as strong core business growth is more than offset by lapping fiscal year 2022 COVID-19 execution, and currency headwinds vs. consensus of $4.49.
  • Raising U.S. Healthcare fiscal 2025 sales target to $11B to $12B, with the segment expected to achieve positive adjusted EBITDA by fiscal year 2024.
  • Increased visibility to the company's long-term growth algorithm, building to low-teens adjusted EPS growth in fiscal year 2025 and beyond.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
errorbox banner

抱歉,当前请求异常(-1)

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial